Pressemeldinger

Invitation to a presentation of the 3rd quarter report 2011

24-10-2011 14:49 CEST
Invitation to a presentation of the 3rd quarter report 2011 Photocure ASA will prese...

Photocure ASA - Presentation of a new commercial strategy for Hexvix®

27-09-2011 11:23 CEST
Photocure, the Norwegian specialty pharmaceutical company focused in dermatology and ca...

Photocure initiates enrollment into phase II trial of visonac® for treatment of moderate to severe acne

18-07-2011 15:15 CEST
Oslo, Norway, 15 July– Photocure ASA (OSE: PHO), a specialty pharmaceutical company foc...

Photocure Announces First Commercial Sale of Allumera® in the US

30-05-2011 16:34 CEST
Allumera is First Photodynamic Cosmetic Oslo, Norway, 27 May – Photocure ASA (OSE:PHO)...

Photocure ASA - Presentation of the 1st quarter 2011 report

26-04-2011 13:49 CEST
Photocure ASA will present its first quarter 2011 report on Wednesday April 27th 2011 ...

FEIL I REGELVERKET FOR INNSATSSTYRT FINANSIERING

26-05-2010 16:35 CEST
Feil i regelverket for Innsatsstyrt Finansiering (ISF) 2010 og NPK programvare 2010

Photocure ASA - Notice of extraordinary general meeting

03-11-2009 14:23 CET
The board of directors of Photocure ASA hereby convenes an extraordinary general meetin...